Funded Tech Companies
eTheRNA
Wondering who provided funding to eTheRNA? Grand Pharmaceutical, Novalis LifeSciences and Omega Funds put venture money into this biopharmaceutical company.
Company Overview
Company Name
eTheRNA
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Galileilaan 19
Niel, 2845
Belgium
Niel, 2845
Belgium
Phone
Website
Email Address
Company Background Information
Overview
eTheRNA is an mRNA technology platform company with integrated capabilities including mRNA construct design and optimization, coupled with specialized expertise in designing and manufacturing customized lipid nanoparticles (cLNP) formulations tailored for the prevention and treatment of various pathological states, providing end-to-end solutions for next generation mRNA therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/24/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bernard Sagaert
Vice President
Stefaan De Koker
VP - Bus. Development
Marina Cools
VP - Bus. Development
Michael Mulqueen
VP - Bus. Development
Dirk Van Broekhoven
VP - Product Management
Phil Challis
Company Investors
- Grand Pharmaceutical
- Novalis LifeSciences (Marijn Dekkers)
- Omega Funds
- EQT Life Sciences
- Private Investors (Kenneth Chien)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs